91É«Ç鯬

Dr Sergey Alexeev

Dr Sergey Alexeev

Senior Research Associate
  • Academic qualifications
    • PhD in Economics, University of Technology Sydney (2015–2020).
    • Master’s in Economics, York University (2013–2014).
    • Master’s in Organisational Sciences (Finance & Control), Université Paris-Dauphine, cum laude (2009–2011).
    • Bachelor’s in Finance (Honours), Graduate School of Management, Saint Petersburg State University (2005–2009).
    • Exchange semester, Trinity College Dublin (University of Dublin).
  • Research governance & service
    • Member, NSW Population & Health Services Research Ethics Committee (PHSREC).
    • Editorial Board, International Journal of Drug Policy; cross-disciplinary peer reviewer.
    • Contributor, Institute for Replication (I4R) and open-science initiatives.
  • Professional memberships
    • Econometric Society; European Association of Labour Economists; allied health-economics and policy networks.
  • Awards & scholarships
    • Recipient of competitive scholarships and fellowships across Europe, North America and Australia.Ìý
  • Compliance & training
    • Human research ethics, privacy & data security (NHMRC frameworks); experience with data-custodian approvals (e.g., BOCSAR, AIHW); full onboarding for PLIDA, HILDA and LSAC.
Faculty of DVC Academic
NG Academic Programs

Sergey Alexeev is an economist–statistician specialising in trial-based and quasi-experimental evaluation, predictive modelling, and cost–benefit analysis. His training spans GSOM–St Petersburg (BFin, Trinity College Dublin exchange), Université Paris-Dauphine (MSc, Finance & Control, cum laude), York University (MA Economics), and a PhD in Economics at UTS. Early-career work at NDARC with Prof Don Weatherburn and BOCSAR used linked administrative data to study drug and alcohol policy, shaping public debate and reform. At the NHMRC Clinical Trials Centre, he was methodological lead on the ENCORE cluster RCT (International Journal of Nursing Studies, 2024) and co-authored the CARE protocol for robust cluster-trial inference.

Sergey currently leads (judge-leniency IV to estimate the causal health effects of imprisonment) and (evaluating drug policy and harm reduction at scale), and builds AI-enabled evidence-synthesis pipelines and place-based decision dashboards for small Australian towns. He partners with Aboriginal and Torres Strait Islander communities through advisory and lived-experience panels, serves on , and is committed to Indigenous data sovereignty and open, replication-ready science (). His service includes the editorial board of the and . His research has been featured in , , and . He is of Ingrian-Finn heritage. More about his research and publications is available at , and his full .

Mobile
+61457871540
Phone
+61-2-9385 0241
Location
Nura Gili – Co-design Health Research & Innovation (CHRI) Lower Ground, Electrical Engineering Building (G17) Balnaves Place, 91É«Ç鯬 Sydney NSW 2052
  • Journal articles | 2025
    Alexeev S, 2025, 'A closer look at Doleac and Mukherjee (2022) and the effects of naloxone access laws on opioid ER admissions', Economic Inquiry,
    Journal articles | 2024
    Douglas C; Alexeev S; Middleton S; Gardner G; Kelly P; McInnes E; Rihari-Thomas J; Windsor C; Morton RL, 2024, 'Transforming nursing assessment in acute hospitals: A cluster randomised controlled trial of an evidence-based nursing core assessment (the ENCORE trial)', International Journal of Nursing Studies, 151,
    Journal articles | 2023
    Alexeev S, 2023, 'Technical change and wage premiums amongst skilled labour: Evidence from the economic transition', Economics of Transition and Institutional Change, 31, pp. 189 - 216,
    Journal articles | 2023
    Alexeev S, 2023, 'Wage equation misrepresents gay wage discrimination: overlooked evidence from Russia', International Journal of Manpower, 44, pp. 470 - 483,
    Journal articles | 2023
    Liang J; Alexeev S, 2023, 'Harm reduction or amplification? The adverse impact of a supervised injection room on housing prices', Regional Science and Urban Economics, 98,
    Journal articles | 2022
    Alexeev S; Weatherburn D, 2022, 'Fines for illicit drug use do not prevent future crime: evidence from randomly assigned judges', Journal of Economic Behavior and Organization, 200, pp. 555 - 575,
    Journal articles | 2022
    Weatherburn D; Alexeev S; Livingston M, 2022, 'Changes in and correlates of Australian public attitudes toward illicit drug use', Drug and Alcohol Review, 41, pp. 1029 - 1040,
    Journal articles | 2021
    Alexeev S; Weatherburn D, 2021, 'The Australian ready-to-drink beverages tax missed its target age group', International Journal of Drug Policy, 95, pp. 103399,
    Journal articles | 2020
    Alexeev S, 2020, 'The role of imputed rents in intergenerational income mobility in three countries', Journal of Housing Economics, 49, pp. 101710,
  • Media | 2021
    Alexeev S, 2021, Australia’s Current Alcohol Tax System Impedes Public Health Policy, The Tax and Transfer Policy Institute (TTPI),
    Media | 2019
    Alexeev S, 2019, Comparing the effects of homeownership on intergenerational income mobility in the US, Germany, and Australia, VoxEU.org – CEPR’s policy portal,

  • EVIDENCE: Evaluating Interventions for Drug Epidemics—Net Community Effectiveness
  • HOPE: Health Outcomes and Post-incarceration Evaluation

2019: The Australian Mathematical Sciences InstituteÌýAPR Scholarship
2015: International Research Scholarship; Ross Milbourne Research Scholarship in Economics; UTS Top Up Scholarship
2013: York Graduate Scholarship for Academic Excellence; York International Tuition Fee Scholarship
2008: GSOM stipend for studying abroad
2006: Best second-year research paper at GSOM

  • Risky alcohol use and violence against women: cause or consequence?
    • Ìý
  • Dual-edged benefits of drug policing: a quarter century’s lesson from a heroin drought
    • ;Ìý
  • A closer look at Doleac and Mukherjee (2022) and the effects of naloxone access laws on opioid ER admissions
    • ;Ìý;Ìý
  • Transforming nursing assessment in acute hospitals: A cluster randomised controlled trial of an evidence-based nursing core assessment (the ENCORE trial)
    • ;Ìý
    • ;Ìý;Ìý
  • Harm reduction or amplification? The adverse impact of a supervised injection room on housing prices
    • ;Ìý
    • ;Ìý;Ìý;Ìý;Ìý;Ìý;Ìý;
  • Wage equation misrepresents gay wage discrimination: overlooked evidence from Russia
    • ;Ìý
  • Fines for illicit drug use do not prevent future crime: evidence from randomly assigned judges
    • ;Ìý
  • Technical change and wage premiums amongst skilled labor: evidence from the economic transition
    • ;Ìý
  • Changes in and correlates of Australian public attitudes toward illicit drug use
    • ;Ìý
    • ;Ìý
  • The Australian ready-to-drink beverages tax missed its target age group
    • ;Ìý
    • ;Ìý
  • The role of imputed rents in intergenerational income mobility in three countries
    • ;Ìý
    • ;Ìý;Ìý;Ìý;Ìý

My Research Supervision

  • Current students
    • — PhD Candidate in Nephrology
      Overview: Net Zero Hub medical lead (NSW Ministry of Health) and National Hypertension Taskforce lead. Our work focuses on cutting-edge trial designs, including Bayesian adaptive trials.
    • Jessica Cornish — PhD Candidate in Criminology
      Overview: Studies police responses to family violence, using systematic reviews and advanced causal methods to evaluate interventions such as arrest and safety notices.
  • Past students
    • — MPhil in Engineering
      Overview: Contributed to the . Now admitted to the graduate program at UC Berkeley, Haas School of Business.